Glenn Baity, VP AND GC at ACADIA PHARMACEUTICALS INC (ACAD), sold 42,000 shares at $30.28 ($1.3M) on 2014-02-26, disclosed to the SEC on 2014-02-28.
Scheduled sale ($1.3M) by VP AND GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACAD | SELL | 2017-10-06 | $3.1M | — | Filing → |
| ACAD | SELL | 2017-09-01 | $924K | — | Filing → |
| ACAD | SELL | 2017-08-11 | $500K | — | Filing → |